{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:14:51Z","timestamp":1783646091477,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Scientific Technological Project of Shiyan City of Hubei Province","award":["22Y58"],"award-info":[{"award-number":["22Y58"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The follicular-phase long GnRHa protocol is a common protocol in COH. This study mainly analyzed the recovery of FSH levels on the day of Gn initiation compared with basal FSH levels on the day of downregulation and studied the correlation with the OSI to discover a new monitoring target for COH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 2286 patients who underwent IVF\/ICSI with the follicular-phase depot GnRH agonist protocol from January 2018 to January 2023 were stratified into cohorts. The primary outcome was the OSI in patients who received the follicular-phase depot GnRH agonist protocol. The GnFSH\/bFSH ratio was used to represent FSH recovery. The enrolled patients were divided into 3 groups according to GnFSH\/bFSH tertiles, and cycle characteristics and outcomes were compared. The relationship between the GnFSH\/bFSH ratio and OSI was analyzed using smoothed curve fitting to determine the threshold or saturation point for the study population. Then, the relationship between the GnFSH\/bFSH and OSI was tested with a multivariable linear regression model after adjusting for potential confounders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result(s)<\/jats:title>\n                    <jats:p>\n                      After adjusting for potential confounders, when the GnFSH\/bFSH ratio was less than 0.8, the OSI increased with increasing GnFSH\/bFSH values (\u03b2\u2009=\u20092.96, 95% CI\u2009=\u20092.37, 3.56,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001). However, there was no significant relationship between GnFSH\/bFSH and OSI values when the ratio was higher than 0.8 (\u03b2\u2009=\u20090.19, 95% CI= -2.02, 2.39,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.8686). In the multiple linear regression model, after full adjustment, each one-unit increase in the GnFSH\/bFSH value was related to increased OSI values (\u03b2\u2009=\u20092.59, 95% CI 2.10, 3.09,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001). In GnFSH\/bFSH tertile groups, patients in T2 (0.37\u20130.56) and T3 (&gt;\u20090.56) had increased OSI values (\u03b2\u2009=\u20090.49, 95% CI 0.24, 0.74,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0001 and \u03b2\u2009=\u20091.25, 95% CI 0.99, 1.51,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.0001, respectively) when compared with patients with values in T1 (&lt;\u20090.37).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion(s)<\/jats:title>\n                    <jats:p>The recovery of serum FSH (GnFSH\/bFSH) after pituitary suppression is an independent risk factor for increased OSI values in women undergoing the follicular-phase depot GnRH agonist protocol.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-026-09246-3","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:04:55Z","timestamp":1779167095000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Does the recovery of serum FSH influence the ovarian sensitivity index in the follicular-phase depot GnRH agonist protocol?"],"prefix":"10.1186","volume":"26","author":[{"given":"Xiaoning","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"issue":"4","key":"9246_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.ss7104a1","volume":"71","author":"S Sunderam","year":"2022","unstructured":"Sunderam S, Kissin DM, Zhang Y, et al. Assisted Reproductive Technology Surveillance - United States, 2018. MMWR Surveill Summ. 2022;71(4):1\u201319.","journal-title":"MMWR Surveill Summ"},{"issue":"Suppl 1","key":"9246_CR2","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1016\/S1472-6483(11)60013-8","volume":"22","author":"AS Penzias","year":"2011","unstructured":"Penzias AS. Improving results with assisted reproductive technologies: individualized patient-tailored strategies for ovulation induction. Reprod Biomed Online. 2011;22(Suppl 1):S83\u20136.","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"9246_CR3","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.rbmo.2017.09.011","volume":"36","author":"C Chalumeau","year":"2018","unstructured":"Chalumeau C, Moreau J, Gatimel N, et al. Establishment and validation of a score to predict ovarian response to stimulation in IVF. Reprod Biomed Online. 2018;36(1):26\u201331.","journal-title":"Reprod Biomed Online"},{"issue":"3","key":"9246_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3349\/ymj.2019.60.3.285","volume":"60","author":"SW Kim","year":"2019","unstructured":"Kim SW, Kim YJ, Shin JH, et al. Correlation between Ovarian Reserve and Incidence of Ectopic Pregnancy after In Vitro Fertilization and Embryo Transfer. Yonsei Med J. 2019;60(3):285\u201390.","journal-title":"Yonsei Med J"},{"key":"9246_CR5","doi-asserted-by":"publisher","first-page":"1086924","DOI":"10.3389\/fendo.2023.1086924","volume":"14","author":"Y He","year":"2023","unstructured":"He Y, Liu L, Yao F, et al. Assisted reproductive technology and interactions between serum basal FSH\/LH and ovarian sensitivity index. Front Endocrinol (Lausanne). 2023;14:1086924.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9246_CR6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1477-7827-9-112","volume":"9","author":"V Biasoni","year":"2011","unstructured":"Biasoni V, Patriarca A, Dalmasso P, et al. Ovarian sensitivity index is strongly related to circulating AMH and may be used to predict ovarian response to exogenous gonadotropins in IVF. Reprod Biol Endocrinol. 2011;9:112.","journal-title":"Reprod Biol Endocrinol"},{"issue":"3","key":"9246_CR7","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.fertnstert.2007.12.013","volume":"91","author":"SL Broer","year":"2009","unstructured":"Broer SL, Mol BW, Hendriks D, Broekmans FJ. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril. 2009;91(3):705\u201314.","journal-title":"Fertil Steril"},{"issue":"1","key":"9246_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/humupd\/dmq034","volume":"17","author":"SL Broer","year":"2011","unstructured":"Broer SL, Dolleman M, Opmeer BC, Fauser BC, Mol BW, Broekmans FJ. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Hum Reprod Update. 2011;17(1):46\u201354.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"9246_CR9","doi-asserted-by":"publisher","first-page":"5329","DOI":"10.1038\/s41598-019-41846-2","volume":"9","author":"W Pan","year":"2019","unstructured":"Pan W, Tu H, Jin L, et al. Comparison of recombinant and urinary follicle-stimulating hormones over 2000 gonadotropin-releasing hormone antagonist cycles: a retrospective study. Sci Rep. 2019;9(1):5329.","journal-title":"Sci Rep"},{"issue":"2","key":"9246_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.fertnstert.2018.06.005","volume":"110","author":"C Niederberger","year":"2018","unstructured":"Niederberger C, Pellicer A, Cohen J, et al. Forty years of IVF. Fertil Steril. 2018;110(2):185\u2013324. e5.","journal-title":"Fertil Steril"},{"issue":"5","key":"9246_CR11","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/humupd\/dmx017","volume":"23","author":"CB Lambalk","year":"2017","unstructured":"Lambalk CB, Banga FR, Huirne JA, et al. GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type. Hum Reprod Update. 2017;23(5):560\u201379.","journal-title":"Hum Reprod Update"},{"issue":"4","key":"9246_CR12","first-page":"197","volume":"33","author":"R Orvieto","year":"2006","unstructured":"Orvieto R, Rabinson J, Meltzer S, Homburg R, Anteby E, Zohav E. GnRH agonist versus GnRH antagonist in ovarian stimulation: is the emperor naked? Clin Exp Obstet Gynecol. 2006;33(4):197\u20139.","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"8","key":"9246_CR13","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1093\/humrep\/deq125","volume":"25","author":"E Bosch","year":"2010","unstructured":"Bosch E, Labarta E, Crespo J, et al. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum Reprod. 2010;25(8):2092\u2013100.","journal-title":"Hum Reprod"},{"issue":"4","key":"9246_CR14","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.fertnstert.2007.10.022","volume":"90","author":"R Orvieto","year":"2008","unstructured":"Orvieto R, Meltzer S, Rabinson J, Zohav E, Anteby EY, Nahum R. GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity. Fertil Steril. 2008;90(4):1294\u20136.","journal-title":"Fertil Steril"},{"issue":"4 Suppl","key":"9246_CR15","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.fertnstert.2008.04.028","volume":"91","author":"R Orvieto","year":"2009","unstructured":"Orvieto R, Homburg R, Meltcer S, Rabinson J, Anteby EY, Scharf S. GnRH agonist versus GnRH antagonist in controlled ovarian hyperstimulation: their role in patients with an unfavorable prognosis a priori. Fertil Steril. 2009;91(4 Suppl):1378\u201380.","journal-title":"Fertil Steril"},{"key":"9246_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1749-6632.1988.tb22263.x","volume":"541","author":"LL Veeck","year":"1988","unstructured":"Veeck LL. Oocyte assessment and biological performance. Ann N Y Acad Sci. 1988;541:259\u201374.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"9246_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12958-022-01014-0","volume":"20","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhao W, Han Y, et al. The follicular-phase depot GnRH agonist protocol results in a higher live birth rate without discernible differences in luteal function and child health versus the daily mid-luteal GnRH agonist protocol: a single-centre, retrospective, propensity score matched cohort study. Reprod Biol Endocrinol. 2022;20(1):140.","journal-title":"Reprod Biol Endocrinol"},{"issue":"4","key":"9246_CR18","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0015-0282(99)00608-1","volume":"73","author":"Y Hsieh","year":"2000","unstructured":"Hsieh Y, Tsai H, Chang C, Lo H. Comparison of a single half-dose, long-acting form of gonadotropin-releasing hormone analog (GnRH-a) and a short-acting form of GnRH-a for pituitary suppression in a controlled ovarian hyperstimulation program. Fertil Steril. 2000;73(4):817\u201320.","journal-title":"Fertil Steril"},{"issue":"Suppl 1","key":"9246_CR19","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1016\/j.ejogrb.2004.01.014","volume":"115","author":"L Dal Prato","year":"2004","unstructured":"Dal Prato L, Borini A, Cattoli M, Bonu MA, Sereni E, Flamigni C. GnRH analogs: depot versus short formulations. Eur J Obstet Gynecol Reprod Biol. 2004;115(Suppl 1):S40\u20133.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"9246_CR20","first-page":"83","volume":"20","author":"V Yadav","year":"2019","unstructured":"Yadav V, Malhotra N, Mahey R, Singh N, Kriplani A. Ovarian Sensitivity Index (OSI): Validating the Use of a Marker for Ovarian Responsiveness in IVF. J Reprod Infertil. 2019;20(2):83\u20138.","journal-title":"J Reprod Infertil"},{"issue":"1","key":"9246_CR21","first-page":"23","volume":"14","author":"S Prasad","year":"2013","unstructured":"Prasad S, Gupta T, Divya A. Correlation of the Day 3 FSH\/LH Ratio and LH Concentration in Predicting IVF Outcome. J Reprod Infertil. 2013;14(1):23\u20138.","journal-title":"J Reprod Infertil"},{"issue":"3","key":"9246_CR22","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S1472-6483(10)60836-X","volume":"11","author":"B Kumbak","year":"2005","unstructured":"Kumbak B, Oral E, Kahraman S, Karlikaya G, Karagozoglu H. Young patients with diminished ovarian reserve undergoing assisted reproductive treatments: a preliminary report. Reprod Biomed Online. 2005;11(3):294\u20139.","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"9246_CR23","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.fertnstert.2013.04.029","volume":"100","author":"NP Polyzos","year":"2013","unstructured":"Polyzos NP, Tournaye H, Guzman L, Camus M, Nelson SM. Predictors of ovarian response in women treated with corifollitropin alfa for in vitro fertilization\/intracytoplasmic sperm injection. Fertil Steril. 2013;100(2):430\u20137.","journal-title":"Fertil Steril"},{"issue":"5","key":"9246_CR24","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s10815-013-9975-3","volume":"30","author":"MF Mutlu","year":"2013","unstructured":"Mutlu MF, Erdem M, Erdem A, et al. Antral follicle count determines poor ovarian response better than anti-Mullerian hormone but age is the only predictor for live birth in in vitro fertilization cycles. J Assist Reprod Genet. 2013;30(5):657\u201365.","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"9246_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3109\/09513599209015549","volume":"6","author":"FJ Broekmans","year":"1992","unstructured":"Broekmans FJ, Bernardus RE, Berkhout G, Schoemaker J. Pituitary and ovarian suppression after early follicular and mid-luteal administration of a LHRH agonist in a depot formulation: decapeptyl CR. Gynecol Endocrinol. 1992;6(3):153\u201361.","journal-title":"Gynecol Endocrinol"},{"issue":"1","key":"9246_CR26","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/oxfordjournals.humrep.a019034","volume":"11","author":"FJ Broekmans","year":"1996","unstructured":"Broekmans FJ, Hompes PG, Lambalk CB, Schoute E, Broeders A, Schoemaker J. Short term pituitary desensitization: effects of different doses of the gonadotrophin-releasing hormone agonist triptorelin. Hum Reprod. 1996;11(1):55\u201360.","journal-title":"Hum Reprod"},{"issue":"6","key":"9246_CR27","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1210\/jcem-68-6-1111","volume":"68","author":"D de Ziegler","year":"1989","unstructured":"de Ziegler D, Steingold K, Cedars M, et al. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease. J Clin Endocrinol Metab. 1989;68(6):1111\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3\u20134","key":"9246_CR28","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.anireprosci.2010.01.007","volume":"119","author":"PM Hastie","year":"2010","unstructured":"Hastie PM, Haresign W. Modulating peripheral gonadotrophin levels affects follicular expression of mRNAs encoding insulin-like growth factor binding proteins in sheep. Anim Reprod Sci. 2010;119(3\u20134):198\u2013204.","journal-title":"Anim Reprod Sci"},{"issue":"2","key":"9246_CR29","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S0015-0282(16)54114-4","volume":"55","author":"Z Ben-Rafael","year":"1991","unstructured":"Ben-Rafael Z, Lipitz S, Bider D, Mashiach S. Ovarian hyporesponsiveness in combined gonadotropin-releasing hormone agonist and menotropin therapy is associated with low serum follicle-stimulating hormone levels. Fertil Steril. 1991;55(2):272\u20135.","journal-title":"Fertil Steril"},{"key":"9246_CR30","doi-asserted-by":"publisher","first-page":"809419","DOI":"10.3389\/fphys.2021.809419","volume":"12","author":"Y Zheng","year":"2021","unstructured":"Zheng Y, Pan Y, Li P, Wang Z, Wang Z, Shi Y. Ovarian Sensitivity Decreased Significantly in Patients With Insulin Resistance Undergoing in vitro Fertilization and Embryo Transfer. Front Physiol. 2021;12:809419.","journal-title":"Front Physiol"},{"issue":"5","key":"9246_CR31","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.fertnstert.2013.06.049","volume":"100","author":"M Huber","year":"2013","unstructured":"Huber M, Hadziosmanovic N, Berglund L, Holte J. Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-releasing hormone-agonist protocol: suggestions for a new principle to solve an old problem. Fertil Steril. 2013;100(5):1270\u20136.","journal-title":"Fertil Steril"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-026-09246-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09246-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-026-09246-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:57:24Z","timestamp":1783645044000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12884-026-09246-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9246"],"URL":"https:\/\/doi.org\/10.1186\/s12884-026-09246-3","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"30 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the principles of the Declaration of Helsinki and was approved by the Ethics Committee of Renmin Hospital, Hubei Medical University. Anonymous data were collected from the Reproductive Medicine Center, Renmin Hospital, Hubei University of Medicine, between January 2018 and January 2023. We informed each patient about the treatment process, treatment options, and risks of in vitro fertilization-embryo transfer before entering the treatment cycle, and signed an informed consent form. At the same time, each patient signed an \u201cinformed consent form for voluntary donation of samples for scientific research\u201d. We confirm that all methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"751"}}